Taro Pharmaceutical Industries Ltd. (TARO)
Company Info
IL0010827181
001082718
Apr 1, 1993
Highlights
$1.62B
$1.43
30.05
$42.65 - $43.03
$43.00
0.91%
3.20
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
TARO
N/A
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of TARO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 3.04% | -2.28% | 0.64% | 0.33% | 0.80% | 0.35% | 2.85% | ||||||
| 2023 | 2.69% | 1.34% | -19.52% | 3.62% | 46.47% | 2.76% | -3.64% | 8.40% | -4.82% | -9.94% | 6.01% | 16.06% | 43.87% |
| 2022 | -6.57% | 4.34% | -11.44% | -9.27% | -6.70% | -1.26% | -1.30% | -5.69% | -10.93% | -0.17% | 0.74% | -3.68% | -42.05% |
| 2021 | 1.80% | -4.34% | 3.15% | 0.37% | -4.05% | 1.32% | -1.06% | -4.75% | -6.18% | -12.67% | -4.19% | -5.88% | -31.75% |
| 2020 | -8.26% | -16.54% | -9.10% | 12.92% | -1.40% | -2.42% | -2.23% | -5.85% | -10.39% | 6.89% | 20.42% | 3.99% | -16.50% |
| 2019 | 12.41% | 7.60% | 5.59% | -0.63% | -13.43% | -8.13% | -5.44% | -4.84% | -1.83% | 7.14% | 19.68% | -9.12% | 3.89% |
| 2018 | -2.88% | -3.48% | 0.60% | 3.28% | 16.66% | -2.76% | -2.96% | -5.90% | -6.95% | 1.23% | 8.45% | -10.14% | -7.39% |
| 2017 | -0.74% | 14.76% | -2.74% | 0.20% | -8.76% | 5.11% | 2.03% | -8.30% | 7.49% | -0.24% | -4.55% | -2.41% | -0.53% |
| 2016 | -5.66% | -0.62% | -1.13% | -2.45% | 4.57% | -0.36% | -3.87% | -9.55% | -12.71% | -8.14% | 0.64% | 3.04% | -31.89% |
| 2015 | 12.36% | -9.27% | -6.64% | -0.30% | 5.75% | -3.37% | -3.02% | -4.13% | 6.95% | 1.63% | -0.27% | 6.71% | 4.29% |
| 2014 | 3.09% | 9.46% | -0.55% | 1.20% | -5.15% | 31.63% | 0.73% | 14.09% | -4.53% | 5.25% | -11.39% | 3.28% | 49.84% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TARO is 66, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Taro Pharmaceutical Industries Ltd. (TARO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Taro Pharmaceutical Industries Ltd. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.86 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.19% |
Monthly Dividends
The table displays the monthly dividend distributions for Taro Pharmaceutical Industries Ltd.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $12.86 | $12.86 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Taro Pharmaceutical Industries Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Taro Pharmaceutical Industries Ltd. was 92.03%, occurring on Apr 30, 2007. Recovery took 1581 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.03% | Dec 3, 2003 | 856 | Apr 30, 2007 | 1581 | Sep 26, 2013 | 2437 |
| -84.66% | Feb 6, 2015 | 2049 | Mar 28, 2023 | — | — | — |
| -67.02% | Feb 3, 1997 | 396 | Aug 31, 1998 | 223 | Jul 23, 1999 | 619 |
| -55.46% | Jul 20, 2001 | 193 | May 1, 2002 | 259 | May 12, 2003 | 452 |
| -54.38% | Oct 19, 1993 | 149 | May 24, 1994 | 677 | Jan 30, 1997 | 826 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Taro Pharmaceutical Industries Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Taro Pharmaceutical Industries Ltd., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 29.0% positive surprise.
Valuation
The Valuation section provides an overview of how Taro Pharmaceutical Industries Ltd. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for TARO, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TARO has a P/E ratio of 30.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for TARO compared to other companies in the Drug Manufacturers - Specialty & Generic industry. TARO currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TARO relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TARO has a P/S ratio of 2.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TARO in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TARO has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |